baber/WOPTO huggingface dataset:
Patent NZ-532945-A (NZ)
Title: Vinylidene chloride polymer (PVDC) film with nanocomposite tie layer
Inventor: GRAH MICHAEL D
IPC: B32B27/30
Filed: 2004-05-14
Abstract: A film is disclosed which comprises: (a) a first layer comprising at least 50 wt. % vinylidene chloride polymer based on the weight of the first layer; (b) a second layer comprising (i) at least 50 wt. % of one or more tie polymers selected from ethylene/vinyl acetate copolymer, ethylene(meth)acrylic acid copolymer, ethylene/C1-12 alkyl (meth)acrylate copolymer, and anhydride-modified polyolefin, based on the weight of the second layer; and (ii) at least 0.5 wt % of nanoparticles dispersed in one or more tie polymer of the second layer based on the weight of the second layer, the nanoparticles having an average size less than 100 nm in at least one direction; and (c) a third layer comprising one or more thermoplastic polymers, wherein the second layer is between and directly adhered to both the first and the third layer. The film provides an enhanced interlayer bond strength between the layers at the elevated temperatures associated with cook-in, retort, and/or pasteurization thermoprocessing. A packaged object comprising the film and method of processing a packaged food product are also disclosed.
Patent NZ-538749-A (NZ)
Title: Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
Inventor: AISSAOUI HAMED
IPC: C07D217/02
Filed: 2003-10-06
Abstract: Sulfonylamino-acetic acid derivatives of formula (I) and their use as active ingredients in the preparation of pharmaceutical compositions is disclosed, wherein the variables are as defined in the specification. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists. These compounds are suitable for the treatment of eating disorders, sleep disorders, cardiovascular disorders, cancer, pain, depression, anxiety, schizophrenia, neuro-degenerative disorders and hyperthermia syndromes.
Patent NZ-538821-A (NZ)
Title: Optical fiber with radiation cured polymeric coating having a specified value of modulus of elasticity
Inventor: ROBA GIACOMO
IPC: C03C25/10
Filed: 2002-10-07
Abstract: Disclosed herein is an optical fiber comprising: (a) a glass portion; (b) at least one protective coating layer disposed to surround said glass portion; said protective coating layer having a modulus of elasticity value between -40 DEG C and +60 DEG C comprised between 5 MPa and 600 MPa, preferably not higher than 500 MPa, more preferably not higher than 450 MPa, much more preferably not higher than 300. Preferably, said protective coating layer is a single protective coating layer which is disposed in contact with said glass portion.
Patent NZ-540934-A (NZ)
Title: Calendered industrial process fabric with pre-selected gap with for calendering
Inventor: NILSSON ANDERS
IPC: D03D15/283
Filed: 2003-11-12
Abstract: Disclosed is a smoothed and durable industrial process fabric and method for producing such a fabric. The fabric may be used as a papermaker's fabric, other industrial process and/or engineered fabric. In any case, the fabric is processed using a device comprising at least two smooth rolls which form a pressure nip, such as a calender, such that at least some of the fabric components are permanently deformed. Preferably, at least one of the rolls is heated to a pre-selected temperature.
Patent NZ-541519-A (NZ)
Title: Synergistic pesticidal formulations for the control of dipteran pests
Inventor: LOWE LIONEL BARRY
IPC: A01N43/22
Filed: 2005-07-28
Abstract: An active composition for preventing, controlling or eradicating Dipteran infestation of domestic animals or their environs, comprising a synergistic combination of at least one A83543 compound and at least one milbemycin or derivative. Has Patent of Addition Number 550023
Patent NZ-542679-A (NZ)
Title: A process for treating recycled polyethylene terephthalate (RPET) flakes
Inventor: HAYWARD DONALD W
IPC: B29C48/04
Filed: 2004-03-12
Abstract: A process for treating recycled polyethylene terephthalate (RPET) flakes is disclosed, which comprises providing a quantity of RPET flakes, comminuting the RPET flakes to prepare RPET particles having an average mean particle size less than about 300 microns, and treating the RPET particles utilizing a low energy process selected from the group consisting of simultaneously melting and mixing the RPET particles by means of a low energy melting device selected from the group consisting of a 2-roll mill, a heated casting roll, and a rotating mandrel, to prepare an RPET melt, and thermally treating the RPET particles to dry or crystallize the RPET particles.
Patent NZ-549785-A (NZ)
Title: Method of fixing a bolt where rotating the bolt expands a section by engaging a head that does not rotate
Inventor: POURTIER FABRICE
IPC: F16B13/06
Filed: 2005-04-06
Abstract: A method of fastening a mounting to a concrete slab by means of a self-expanding and self-undercutting bolt (1) is disclosed. The bolt (1) has a threaded shaft (10) having an end part with expanding lugs (17), and an expansion core (20) threadedly coupled to the shaft (10). The expansion core (20) has an anti-rotation head (24) with which to grip the sides of the hole when inserted. The method including the steps of drilling a hole in the slab to at least a desired depth of bolt (1) insertion and driving the bolt (1) to the desired depth leaving a free end of the threaded shaft (10) protruding from the hole. The anti-rotation head (24) of the expansion core (20) engages with the sidewall of the hole so as to prevent rotation of the expansion core (20) relative to the hole. A tool is used to rotate the shaft portion relative to the hole with a fastening head (14) integrally formed with the threaded shaft (10). The anti-rotation head (24) is pulled toward the expansion lugs (17) to cause the expanding lugs (17) move against the sidewall of the hole to anchor the bolt (1). The mounting is secured to the slab by threading a fastening nut onto the threaded shaft (10) over the mounting and tightening the fastening nut.
Patent NZ-552829-A (NZ)
Title: Microorganisms and cells for diagnosis and therapy of tumors
Inventor: SZALAY ALADAR A
Filed: 2002-07-31
Abstract: Disclosed are diagnostic and pharmaceutical compositions comprising a virus containing a DNA sequence encoding a detectable protein or a protein capable of inducing a detectable signal, e.g. a luminescent or fluorescent protein, and, in a particular embodiment, furthermore (a) DNA sequence(s) encoding (a) protein(s) suitable for tumor therapy and/or elimination of metastatic tumors, e.g. a cytotoxic or cytostatic protein.
Patent NZ-555810-A (NZ)
Title: 1-({6-benzyloxy-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidine derivatives and medicinal uses thereof
Inventor: HABASHITA HIROMU
IPC: A61K31/12
Filed: 2005-12-12
Abstract: Disclosed are 1-({6-benzyloxy-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidine derivatives as represented by the general formula (IC-2), wherein Z represents a carboxyl group, a hydroxy group, a hydroxamic acid group, a sulfonic acid group, a boronic acid group, a carbamoyl group, a sulfamoyl group, a-P(=O)(OR2)(OR3) group, or a tetrazolyl group; and wherein the remaining substituents are as defined herein. Of particular importance are the compounds 1-({6-[(2-methoxy-4-propylbenzyl)oxy]-1-methyl-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidinecarboxylic acid, 1-[(6-{[2,4-bis(trifluoromethyl)benzyl]oxy}-1-methyl-3,4-dihydro-2-naphthalenyl)methyl]-3-azetidinecarboxylic acid monohydrate, 1-({6-[(2-methoxy-4-propylbenzyl)oxy]-1-methyl-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidinecarboxylic acid hydrochloride, 1-[(6-{[2,4-bis(trifluoromethyl)benzyl]oxy}-1-methyl-3,4-dihydro-2-naphthalenyl)methyl]-3-azetidinecarboxylic acid hydrochloride, sodium 1-({6-[(2-methoxy-4-propylbenzyl)oxy]-1-methyl-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidinecarboxylate, potassium, 1-({6-[(2-methoxy-4-propylbenzyl)oxy]-1-methyl-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidinecarboxylate, 1-({6-[(2-methoxy-4-propylbenzyl)oxy]-1-methyl-3,4-dihydro-2-naphthalenyl}methyl)-3-azetidinecarboxylic acid hemicalcium salt, sodium 1-[(6-{[2,4-bis(trifluoromethyl)benzyl]oxy}-1-methyl-3,4-dihydro-2-naphthalenyl)methyl]-3-azetidinecarboxylate, and potassium 1-[(6-{[2,4-bis(trifluoromethyl)benzyl]oxy}-1-methyl-3,4-dihydro-2-naphthalenyl)methyl]-3-azetidinecarboxylate. Also disclosed is a pharmaceutical composition which comprises a compound as defined above, for the prevention and/or treatment of a disease related to EDG-1, EDG-6 and/or EDG-8, and specifically for the treatment of diseases related to rejection in transplantation of an organ, tissues, and/or cells, autoimmune disease, allergic disease, asthma, multiple organ failure, ischemia-reperfusion injury, lymphoma, malignant tumor, and/or neurodegenerative disease.
Patent NZ-562169-A (NZ)
Title: Solubility of cellulose in imidazolium derived ionic liquids with the addition of amino bases
Inventor: MAASE MATTHIAS
IPC: C08B1/00
Filed: 2006-04-12
Abstract: Disclosed is a solution comprising cellulose, an ionic liquid as a solvent and 6 - 30% by weight of a nitrogen-comprising base, based on the total weight of the solution, wherein the ionic liquid comprises at least one cation of formula (IVe), wherein; R is unbranched and unsubstituted alkyl; R1 is unbranched or branched alkyl which is unsubstituted; and the radicals R2 to R4 are each, independently of one another, hydrogen, or unbranched or branched alkyl which is unsubstituted; and wherein the nitrogen-comprising base is an imidazole compound which is derived from the quaternary compounds of the formula (IVe), with the radical R forming the quaternary compounds not being present and R1-R4 independently of one another, are as defined above.
Patent NZ-572840-A (NZ)
Title: N- ( 2-thiazolyl) -amide derivatives as gsk-3 inhibitors
Inventor: MARTINEZ GIL ANA
IPC: A61K31/427
Filed: 2007-04-27
Abstract: Disclosed is a thiazole carboxamide pyridine compound of formula (I) where the substituents are as disclosed in the specification. Also disclosed is the use of a compound of formula (I) for the manufacture of a medicament for treating a disease or condition mediated by GSK-3 selected from diabetes, conditions associated with diabetes, chronic neurodegenerative conditions including dementias such as Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex, Pick's disease, Gerstmann-Sträussler-Scheinker disease, Greutzfeld-Jakob disease, prion protein cerebral amyloid angiopathy, corticobasal degeneration, frontotemporal dementia, Huntington's Disease, AIDS associated dementia, amyotrophic lateral sclerosis, multiple sclerosis and neurotraumatic diseases such as acute stroke, epilepsy, mood disorders such as depression, schizophrenia and bipolar disorders, manic depressive disorder, promotion of functional recovery post stroke, cerebral bleeding (for example, due to solitary cerebral amyloid angiopathy), hair loss, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, brain injury, especially traumatic brain injury, leukopenia, Down's syndrome, Lewy body disease, inflammation, chronic inflammatory diseases and immunodeficiency. Further disclosed is a pharmaceutical composition comprising a compound of formula (I) and a process for preparing a compound of formula (I).
Patent NZ-573351-A (NZ)
Title: Process valve actuator with magnetostrictive position sensor
Inventor: SPLIETHOFF NORBERT
IPC: F16K31/00
Filed: 2008-12-03
Abstract: A device for actuating a process valve, for use in foodstuffs technology, has a valve member, an actuating element that is moved upon the shifting of the valve in such a way that the position of the actuating element is a measure of the position of the valve member, and a magnetostrictive sensor 151 in a sensor module 150 that provides an output signal that is a measure of the position of the actuating element.
Patent NZ-573482-A (NZ)
Title: A method of configuring intelligent electronic devices to facilitate standardized communication messages among a plurality of ieds within a network
Inventor: BOSOLD MARK J
IPC: G06F9/44
Filed: 2007-07-23
Abstract: A configuration tool for creating a description file for an intelligent electronic device (lED) configured in accordance with the IEC-61850 standard for GOOSE messaging with other intelligent electronic devices (IEDs) comprises an editing tool for creating a section in the description file which indicates which GOOSE message the lED should receive. A configuration tool for creating a description file for an intelligent electronic device (lED) configured in accordance with the IEC-61850 standard for messaging with other intelligent electronic devices (IEDs) comprises an editing tool for creating a section in the description file capable of linking to logic functions of the lED for performing programmable data binding or dynamic data binding. A method for selectively receiving messages from an intelligent electronic device (lED) configured in accordance with the IEC-61850 standard for messaging with other intelligent electronic devices (IEDs) is disclosed. The message includes a number of bits. The method includes creating a message including at least one bit representative of the quality of the message, and selectively receiving the message by analyzing the bit representative of the quality of the message. A method for optimizing file space and improving execution speed of an intelligent electronic device (lED) configured in accordance with the IEC-61850 standard for messaging with other intelligent electronic devices (IEDs) is disclosed. The message includes a number of bits. The method includes creating a message including at least one bit indicating important data bits, and selectively receiving the message based on the bit indicating important data in order to prioritize the important data bits.
Patent NZ-578384-A (NZ)
Title: Spinach line SSB66-1087F
Inventor: BAERENDS BERNARDUS
IPC: A01H5/12
Filed: 2009-07-14
Abstract: Disclosed is a seed of Spinach line SSB66-1087F a sample of seed of said line having been deposited under ATCC Accession Number PTA-9186. Also disclosed are corresponding plants and tissue cultures, and the use of the plants in plant breeding.
Patent NZ-581183-A (NZ)
Title: Combination of a cytotoxic antineoplastic agent and a cyclin dependent kinase (CDK) inhibitor for the treatment of cancer
Inventor: RATHOS MAGGIE
IPC: A01N43/90
Filed: 2007-05-15
Abstract: Disclosed is a pharmaceutical combination comprising a cytotoxic antineoplastic agent selected from the group consisting of paclitaxel, docetaxel, doxorubicin, and gemcitabine or a pharmaceutically acceptable salt thereof; and a CDK inhibitor or an enantiomer or a pharmaceutically acceptable salt or solvate thereof, wherein said CDK inhibitor is represented by formula I, wherein the substituents are as described within the specification. Further disclosed is the use of a CDK inhibitor of formula I in combination with a cytotoxic antineoplastic agent selected from the group consisting of paclitaxel, docetaxel, doxorubicin, and gemcitabine or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of cancer selected from the group consisting of breast cancer, small cell lung cancer, non small-cell lung cancer, ovarian cancer, pancreatic cancer, gastric cancer, colorectal cancer and hepatocellular carcinoma.
Patent NZ-582412-A (NZ)
Title: Novel amide derivative for inhibiting the growth of cancer cells
Inventor: LEE CHANG GON
IPC: C07D403/12
Filed: 2008-06-05
Abstract: The disclosure relates to amide derivatives of formula (I) and a pharmaceutically acceptable salt thereof which selectively and effectively inhibit the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor (EGFR) and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase, a pharmaceutical composition comprising same as an active ingredient, and uses thereof in the manufacture of a medicament.
Patent NZ-585732-A (NZ)
Title: Methods of treating fatty liver disease including non-alcoholic steatohepatitis (nash) using cysteamine products
Inventor: DOHIL RANJAN
IPC: A01N31/00
Filed: 2008-11-28
Abstract: Disclosed is the use of cysteamine or a pharmaceutically acceptable salt thereof, or cystamine or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for treating non-alcoholic steatohepatitis (NASH).
Patent NZ-586068-A (NZ)
Title: Methoxyimino compounds and fungicide composition comprising same
Inventor: KIM JOO-KYUNG
IPC: C07C251/48
Filed: 2008-12-05
Abstract: Disclosed herein are methoxyimino compounds of formula (I), wherein A is O or O-N=C(CH3); R1 is H, halogen, C1-3 alkyl, or C1-3 alkoxy; R2 is H or C1-3 alkoxy; R3 is H, or C1-4 alkyl substituted with one or more C1-4 alkyl groups or halogens; X and X' are each independently halogen; and W is O or NH, methods for their preparation, compositions comprising said compounds and uses thereof as fungicides.
Patent NZ-586973-A (NZ)
Title: Inhler with puncturing of blisters of strip by actuator due to cap rotation
Inventor: GIBBINS GRAHAM
IPC: A61M15/00
Filed: 2009-01-22
Abstract: 586973 An inhaler (10) comprising a housing (11) to receive a strip (14) having a plurality of blisters (14a), each blister (14a) having a puncturable lid (14c) and containing a dose of medicament for inhalation by a user, a mouthpiece (13) through which a dose of medicament is inhaled by a user, a cap (12) to cover the mouthpiece (13) and a blister piercing element (16) to pierce the lid (14c) of a blister (14a) is disclosed. The cap (12) is rotatable to drive the strip (14) to sequentially move each blister (14a) into alignment with the blister piercing element (16) and an actuator is operable in response to rotation of the cap (12) to cause the blister piercing element (16) to puncture the lid (14c) of an aligned blister (14a) such that, when a user inhales through the mouthpiece (13), an airflow through the blister (14a) is generated to entrain the dose contained therein and carry it out of the blister (14a) and via the mouthpiece into the user's airway. A link arm is pivotally mounted to the housing and couples the cap to the actuator and pivots in response to rotation of the cap to rotate the actuator, the actuator and the cap being separate components, the mouthpiece being immovably fixed to the housing and the actuator being movable so that it rotates relative to the mouthpiece in response to rotation of the cap to cause the blister piercing element to puncture the lid of an aligned blister.
Patent NZ-587169-A (NZ)
Title: Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
Inventor: KAPOOR RITESH
IPC: A61K9/14
Filed: 2009-02-06
Abstract: Disclosed is a pharmaceutical composition comprising entacapone or salts thereof along with one or more sugar alcohols sucha s mannitol; wherein the entacapone is co-micronized with one or more sugar alcohols.
Patent NZ-588094-A (NZ)
Title: Potting head for hollow fibre filter module
Inventor: MCMAHON ROBERT JAMES
IPC: B01D63/04
Filed: 2005-08-19
Abstract: A potting head for mounting porous hollow membranes 8 includes a preformed potting element 6 having cavities 30 for receiving curable potting material which in use when cured supports the membranes. The potting element is formed with through openings 12 for the communication of fluid through the element.
Patent NZ-590407-A (NZ)
Title: Process for producing a multilayer composite which is coated with liquid then dried in an oven and rolled up
Inventor: BRATHUHN RUDI
IPC: A61K9/70
Filed: 2009-07-20
Abstract: 590407 Disclosed is a process for producing a multilayer composite in a cleaning in place (ClP) capable coating installation and use of the multilayer composite produced thereby for transdermal application or application in body cavities. The process comprises: applying one or more layers to a substrate by coating using a liquid component to form a coated substrate (4); drying the coated substrate (4) in a drying oven (5) having an air supply (6) and multiple drying zones to form a dried coated substrate; rolling up the dried coated substrate (8); and cleaning the installation. The air supply (6) entirely comprises fresh air during the drying of the coated substrate (4) in the drying oven (5). The interior of the drying oven (5) is embodied such that it can be cleaned in a controlled fashion.
Patent NZ-591447-A (NZ)
Title: Cylindrical catalyst unit having circular holes extending therethrough
Inventor: BIRDSALL DAVID JAMES
IPC: B01J35/02
Filed: 2009-08-24
Abstract: A catalyst unit (10) is described in the form of a cylinder (12) having a length C and diameter D, which has 3 to 10 circular holes (14) extending therethrough. The cylinder has domed ends of lengths A and B, such that (A+B+C)/D is in the range 0.50 to 2.00, and (A+B)/C is in the range 0.40 to 5.00. The catalyst or catalyst unit preferably has one or more flutes running along its length. The catalyst may be used particularly in steam reforming reactors.
Patent NZ-592766-A (NZ)
Title: 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
Inventor: MAUGER JACQUES
IPC: C07D471/14
Filed: 2006-07-18
Abstract: Disclosed are 8-oxo-9-(hetero)aryl-4,5,6,7,8,9-hexahydro-2H-pyrrolo[3,4-b]quinoline derivatives as represented by the general formula (I), wherein: X is N or CR7; R2 is substituted aryl or substituted heteroaryl; Y, Y' and Y" each independently represent a substituent selected from CH2, CHR5, CR5R6, C=O, O, S, NH, and NR7; or together represent a substituent selected from -CH2-O-(C=O)-, -(CH2)4- and -(CH2)2-chain moiety; and wherein the remaining substituents are as defined herein. Further disclosed is a pharmaceutical composition comprising a compound as defined above and a pharmaceutically acceptable excipient, for treating a pathological condition such as cancer, psoriasis, leukaemia and lupus.
Patent NZ-593801-A (NZ)
Title: Prophylactic and therapeutic agents and uses therefor
Inventor: KUMAR SHARAD
IPC: A61K38/17
Filed: 2006-09-01
Abstract: Disclosed is the use of the proteins Ndfipl (formally N4WBP5) or Nedd4 or a nucleic acid molecule encoding Ndfipl or Nedd4 in the manufacture of a medicament in the treatment of a subject prior to, during or following a stroke. Further disclosed is a method for determining the presence of a stroke event in a subject said method comprising determining the levels of Ndfipl or Ndfipl-expression or Ndfipl-Nedd4 interaction: in an in vitro sample from the subject wherein an increase in levels or expression relative to a threshold level determined prior to a stroke event is indicative of progression of the stroke event.
Patent NZ-594873-A (NZ)
Title: Hydrofluoroalkanes as carrier solvents for timber preservation
Inventor: KENNEDY MICHAEL
IPC: B27K3/02
Filed: 2010-03-12
Abstract: The disclosure relates to a method of treating refractory timber namely; heartwood of radiata pine, Spruce (Picea) species such as Norway spruce (P. abies) and sitka spruce (P. sitchensis); Douglas fir (P., menziesii), fir (A. Alba), poplar, willow, sapwood of cypress pine and certain eucalypt and pine species such as heartwood of messmate (E. obliqua), larch, western red cedar, European oak and American white oak with biocidal agents such as copper or tin naphthenate or other metallic or non-metallic biocides. The said method comprising contacting the timber, wood products, lumber with a solution of biocide in a hydrofluroalkane solvent that is in a non-supercritical state. The timber product produced by this method is also disclosed.